The 2023 Florida Statutes (including Special Session C)
|
||||||
|
. . . . § 601.25). . . . See 21 C.F.R. § 601.25(a), (e). . . . See id. § 601.25(f). After receiving and reviewing comments, the FDA publishes a final order. . . . . § 601.25(g). . . . function in the diagnosis, cure, mitigation, treatment, or prevention of disease in man.” 21 C.F.R. § 601.25 . . .
. . . . § 601.25. . . .
. . . . § 601.25(d). . . . . § 601.25(d)(2). . . . Id. § 601.25(a) & (e). . . . Id. § 601.25(f). . . . Id. § 601.25(g) &G). . . . .
. . . According to 21 C.F.R. 601.25, the panel was: “(1) to evaluate the safety and effectiveness of biological . . . As required by 21 C.F.R. § 601.25, the proposed rule required public comment, and the FDA received four . . . Anthrax Vaccine (Dec. 30, 2003). . 21 C.F.R. § 601.4 (2004); 21 C.F.R. § 601.4 (1977). . 21 C.F.R. § 601.25 . . . Id. § 601.25(a), (b). . Id. § 601.25(a). . . . .
. . . . § 601.25. . . . See 21 C.F.R. § 601.25(a). Each panel must submit a report. See § 601.25(e). . . . .” § 601.25(e)(1). . . . See §§ 601.25(g), 601.25®. C. . . . . § 601.25(f). . . .
. . . . §§ 601.2, 601.12, 601.25). . . .
. . . . § 601.25. . . .
. . . First, Tucker argues that the trial court erred in imposing $601.25 in costs of prosecution because the . . .
. . . Section 601.25 states: The Department of Citrus by rule or regulation shall determine the method by which . . .
. . . . §§ 601.2, 601.12, 601.25. . . .
. . . . §§ 601.2, 601.12, 601.25. . . .
. . . . § 601.25(a)-(c). In addition, standards for safety, effectiveness, and labeling are established. . . . Id. § 601.25(d). . . .
. . . . §§ 600.20, 601.1, 601.2, 601.25, 610.1, 620.1-620.7. . . .
. . . . § 601.25. . . .
. . . . § 601.25. . 21 C.F.R. § 211, subpart B. . 21 C.F.R. § 600.20. . 21 C.F.R. § 610, subparts A and B. . . . See, 21 C.F.R., §§ 601.25, 601.26. . . . See, § 601.25(e)(1). (2) Category II: Biological products determined by the panel to be unsafe, ineffective . . . See, § 601.25(e)(2). (3) Category III: Biological products determined by the panel not to fall within . . . See, § 601.25(e)(3). . . .
. . . Fidelibus claims a total of 601.25 days of accumulated time from 1965. . . .
. . . .) $ 601.25 NICHOLIS J. . . .
. . . . § 601.25; (7) failing to enact regulations which would assure the safety of trivalent oral polio vaccine . . .
. . . . § 601.25; (7) failing to enact regulations which would assure the safety of trivalent oral polio vaccine . . . pleaded that the government is liable for failing to follow the review procedures set out in 21 C.F.R. § 601.25 . . .
. . . Costs in the amount of $601.25 are hereby taxed against the Respondent. It is so ordered. . . .